Sfoglia per AUTORE
LOFT A
Collezione AO Cuneo

  

Items : 3

In vivo treatment sensitivity testing with positron emission tomography/computed tomography after one cycle of chemotherapy for Hodgkin lymphoma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2014 Sep 1;32(25):2705-11. doi: 10.1200/JCO.2013.53.2838. Epub 2014 Jul 28.

2014
AO Cuneo

Coleman M; Stern R; Diehl L; Zinzani PL; Nanni C; Czuczman MS; Lamonica D; Specht L; Loft A; Danielewicz I; Biggi A; Malkowski B; Zaucha JM; Kostakoglu L; Hutchings M;

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale. in Haematologica / Haematologica. 2014 Jun;99(6):1107-13. doi: 10.3324/haematol.2013.103218. Epub 2014 Mar 21.

2014
AO Cuneo

Gallamini A; Barrington SF; Hutchings M; Luminari S; Salvi F; Viviani S; Bolis S; Rusconi C; Brice P; Dann EJ; Trentin L; Casasnovas O; Pulsoni A; Coleman M; Hofman MS; Rigacci L; Seymour JF; Zaucha JM; Loft A; Mikhaeel GN; Biggi A; Meignan M; Kostakoglu L; Gregianin M; Chauvie S;

Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2007 Aug 20;25(24):3746-52. doi: 10.1200/JCO.2007.11.6525. Epub 2007 Jul 23.

2007
AO Cuneo

Biggi A; Vitolo U; Stelitano C; D'Amore F; Di Raimondo F; Loft A; Patti C; Hansen M; Merli F; Specht L; Rigacci L; Hutchings M; Gallamini A; Sancetta R; Trentin L; Luminari S; Iannitto E; Viviani S; Pierri I; Levis A;